Correlation Between Milestone Pharmaceuticals and Cullinan Oncology
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and Cullinan Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and Cullinan Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and Cullinan Oncology LLC, you can compare the effects of market volatilities on Milestone Pharmaceuticals and Cullinan Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of Cullinan Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and Cullinan Oncology.
Diversification Opportunities for Milestone Pharmaceuticals and Cullinan Oncology
-0.56 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Milestone and Cullinan is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and Cullinan Oncology LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cullinan Oncology LLC and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with Cullinan Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cullinan Oncology LLC has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and Cullinan Oncology go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and Cullinan Oncology
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to under-perform the Cullinan Oncology. In addition to that, Milestone Pharmaceuticals is 1.11 times more volatile than Cullinan Oncology LLC. It trades about -0.02 of its total potential returns per unit of risk. Cullinan Oncology LLC is currently generating about 0.03 per unit of volatility. If you would invest 1,076 in Cullinan Oncology LLC on August 26, 2024 and sell it today you would earn a total of 178.00 from holding Cullinan Oncology LLC or generate 16.54% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. Cullinan Oncology LLC
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| Cullinan Oncology LLC |
Milestone Pharmaceuticals and Cullinan Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and Cullinan Oncology
The main advantage of trading using opposite Milestone Pharmaceuticals and Cullinan Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, Cullinan Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cullinan Oncology will offset losses from the drop in Cullinan Oncology's long position.The idea behind Milestone Pharmaceuticals and Cullinan Oncology LLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Cullinan Oncology vs. Eliem Therapeutics | Cullinan Oncology vs. HCW Biologics | Cullinan Oncology vs. Scpharmaceuticals | Cullinan Oncology vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |